Gambogic acid targets HSP90 to alleviate DSS-induced colitis via inhibiting the necroptosis of intestinal epithelial cells

被引:1
作者
Wang, Yuanyuan [1 ,2 ]
Liu, Siqi [1 ,2 ]
Lu, Keyi [1 ,2 ]
Xu, Erping [1 ,2 ]
Wang, Zhibin [3 ]
机构
[1] Henan Univ Chinese Med, Collaborat Innovat Ctr Res & Dev Whole Ind Chain Y, Zhengzhou, Henan, Peoples R China
[2] Henan Univ Chinese Med, Acad Chinese Med Sci, Zhengzhou, Henan, Peoples R China
[3] Naval Med Univ, Sch Anesthesiol, Dept Crit Care Med, Shanghai, Peoples R China
关键词
Gambogic acid; ulcerative colitis; necroptosis; Hsp90; IECs; INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; MECHANISMS; DEATH;
D O I
10.3389/fphar.2025.1586705
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Abnormal elevations in the mortality of intestinal epithelial cells (IECs) are indicative of intestinal inflammation. Necroptosis of IECs represents a pro-inflammatory form of cell death, and modulation of IECs necroptosis may mitigate subsequent intestinal inflammation and preserve the integrity of the intestinal barrier. Currently, safe and effective preventive measures are lacking. In the Traditional Chinese Medicine theory, necroptosis of IECs leads to the destruction of the intestinal barrier in a manner associated with "heat and toxicity", exacerbating intestinal inflammation. Heat shock protein 90 (HSP90) has been identified as a regulator of key proteins involved in necroptosis signal pathway including RIPK1/3 and MLKL. Gambogic acid (GA), the primary active compound found in Garcinia hanburii Hook. f., a traditional Chinese medicine used for detoxification and hemostasis, has not been studied for its potential therapeutic effects in ulcerative colitis previously. This study investigated the protective effects of GA on dextran sodium sulfate (DSS)-induced colitis in mice, as well as the underlying molecular mechanisms. GA was observed to significantly ameliorate DSS-induced enteritis and enhance intestinal barrier function. Concurrently, it reduced the phosphorylated expression levels of RIPK1/3 and MLKL. The underlying mechanism may be related to the suppression of HSP90 expression.
引用
收藏
页数:18
相关论文
共 50 条
[31]   Studies on the toxicity of gambogic acid in rats [J].
Qi, Qi ;
You, Qidong ;
Gu, Hongyan ;
Zhao, Li ;
Liu, Wei ;
Lu, Na ;
Guo, Qinglong .
JOURNAL OF ETHNOPHARMACOLOGY, 2008, 117 (03) :433-438
[32]   Combining the HSP90 inhibitor TAS-116 with metformin effectively degrades the NLRP3 and attenuates inflammasome activation in rats: A new management paradigm for ulcerative colitis [J].
Shaaban, Ahmed A. ;
Abdelhamid, Amir Mohamed ;
Shaker, Mohamed E. ;
Cavalu, Simona ;
Maghiar, Adrian Marius ;
Alsayegh, Abdulrahman A. ;
Babalghith, Ahmad O. ;
El-Ahwany, Eman ;
Amin, Noha A. ;
Mohammed, Osama A. ;
Eissa, Hanan ;
Gaafar, Ahmed Gaafar Ahmed ;
Batiha, Gaber El-Saber ;
Saber, Sameh .
BIOMEDICINE & PHARMACOTHERAPY, 2022, 153
[33]   HSP90 at the hub of protein homeostasis: emerging mechanistic insights [J].
Taipale, Mikko ;
Jarosz, Daniel F. ;
Lindquist, Susan .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2010, 11 (07) :515-528
[34]   Gambogic Acid Mitigates Nephropathy by Inhibiting Oxidative Stress and Inflammation in Diabetic Rats [J].
Thongrung, Ruttiya ;
Lapmanee, Sarawut ;
Bray, Penjai Thongnuanjan ;
Suthamwong, Patlada ;
Deandee, Suwaporn ;
Pangjit, Kanjana ;
Yuajit, Chaowalit .
INTERNATIONAL JOURNAL OF MOLECULAR AND CELLULAR MEDICINE, 2025, 14 (01) :448-461
[35]   Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 (DNL747) for neurodegenerative disorders: Randomized, placebo-controlled, double-blind phase I/Ib studies in healthy subjects and patients [J].
Vissers, Maurits F. J. M. ;
Heuberger, Jules A. A. C. ;
Groeneveld, Geert Jan ;
Nijhuis, Jerome Oude ;
De Deyn, Peter Paul ;
Hadi, Salah ;
Harris, Jeffrey ;
Tsai, Richard M. ;
Cruz-Herranz, Andres ;
Huang, Fen ;
Tong, Vincent ;
Erickson, Rebecca ;
Zhu, Yuda ;
Scearce-Levie, Kimberly ;
Hsiao-Nakamoto, Jennifer ;
Tang, Xinyan ;
Chang, Megan ;
Fox, Brian M. ;
Pomponio, Robert J. ;
Alonso-Alonso, Miguel ;
Zilberstein, Moshe ;
Atassi, Nazem ;
Troyer, Matthew D. ;
Ho, Carole .
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022, 15 (08) :2010-2023
[36]   Targeting the HSP90-CDC37-kinase chaperone cycle: A promising therapeutic strategy for cancer [J].
Wang, Lei ;
Zhang, Qiuyue ;
You, Qidong .
MEDICINAL RESEARCH REVIEWS, 2022, 42 (01) :156-182
[37]   Targeting programmed cell death in inflammatory bowel disease through natural products: New insights from molecular mechanisms to targeted therapies [J].
Wang, Mengjie ;
Wang, Zhiyuan ;
Li, Zhichao ;
Qu, Yuan ;
Zhao, Jiting ;
Wang, Lei ;
Zhou, Xinpeng ;
Xu, Ziqi ;
Zhang, Di ;
Jiang, Ping ;
Fan, Bing ;
Liu, Ying .
PHYTOTHERAPY RESEARCH, 2025, 39 (04) :1776-1807
[38]   The traditional herb Sargentodoxa cuneata alleviates DSS-induced colitis by attenuating epithelial barrier damage via blocking necroptotic signaling [J].
Wang, Yuanyuan ;
Zhang, Bo ;
Liu, Siqi ;
Xu, Erping ;
Wang, Zhibin .
JOURNAL OF ETHNOPHARMACOLOGY, 2024, 319
[39]   Randomized clinical study of safety, pharmacokinetics, and pharmacodynamics of RIPK1 inhibitor GSK2982772 in healthy volunteers [J].
Weisel, Kathleen ;
Scott, Nicola E. ;
Tompson, Debra J. ;
Votta, Bartholomew J. ;
Madhavan, Sujith ;
Povey, Kat ;
Wolstenholme, Allen ;
Simeoni, Monica ;
Rudo, Todd ;
Richards-Peterson, Lauren ;
Sahota, Tarjinder ;
Wang, J. Gene ;
Lich, John ;
Finger, Joshua ;
Verticelli, Adeline ;
Reilly, Michael ;
Gough, Peter J. ;
Harris, Philip A. ;
Bertin, John ;
Wang, Mei-Lun .
PHARMACOLOGY RESEARCH & PERSPECTIVES, 2017, 5 (06)
[40]   A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis [J].
Weisel, Kathy ;
Scott, Nicola ;
Berger, Scott ;
Wang, Susanne ;
Brown, Kurt ;
Powell, Marcy ;
Broer, Matthijs ;
Watts, Clarissa ;
Tompson, Debra J. ;
Burriss, Susan W. ;
Hawkins, Simon ;
Abbott-Banner, Kathy ;
Tak, Paul Peter .
BMJ OPEN GASTROENTEROLOGY, 2021, 8 (01)